Autor(es)

Passos, Julia Sapienza ; Dartora, Vanessa F. M. C. ; Salata, Giovanna Cassone ; Malago, Isabella Draszesski ; Lopes, Luciana B.

• Tipo de documento: Artigo Científico
• Fonte: International Journal of Pharmaceutics; v. 635, p. 15-pg., 2023-02-14.

Resumo

Breast cancer is a major public health problem, affecting millions of people. It is a very heterogeneous disease, with localized and invasive forms, and treatment generally consists of a combination of surgery and radiotherapy followed by administration of estrogen receptor modulators or aromatase inhibitors. Given its heterogeneity, management strategies that take into consideration the type of disease and biological markers and can provide more personalized and local treatment are required. More recently, the intraductal administration (i.e., into the breast ducts) of drugs has attracted significant attention due to its ability of providing drug distribution through the ductal tree in a minimally invasive manner. Although promising, intraductal administration is not trivial, and difficulties in duct identification and cannulation are important challenges to the further development of this route. New drug delivery strategies such as nanostructured systems can help to achieve the full benefits of the route due to the possibility of prolonging tissue retention, improving targeting and selectivity, increasing cytotoxicity and reducing the frequency of administration. This review aims at discussing the potential benefits and challenges of intraductal administration, focusing on the design and use of nanocarriers as innovative and feasible strategies for local breast cancer therapy and prevention. (AU)

• Processo FAPESP: 18/13877-1 - Nanocarreadores para a quimioprevenção e tratamento localizado de tumores de mama
• Beneficiário: Luciana Biagini Lopes
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores - Fase 2
• Processo FAPESP: 17/04174-4 - Desenvolvimento e avaliação de nanocarreadores catiônicos bioadesivos como plataforma para localização de piplartina na mama visando o tratamento tumoral
• Beneficiário: Vanessa Franco Carvalho Dartora
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 20/01208-8 - Sistemas nanoestruturados bioadesivos para administração intraductal e tratamento localizado do Câncer de Mama
• Beneficiário: Julia Sapienza Passos
• Modalidade de apoio: Bolsas no Brasil - Doutorado Direto
• Processo FAPESP: 14/50928-2 - INCT 2014: Nanotecnologia Farmacêutica: uma abordagem transdisciplinar
• Beneficiário: Maria Vitória Lopes Badra Bentley
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 19/26048-6 - Desenvolvimento e aplicação de nanocarreadores multifuncionais para entrega intraductal de quimioterápicos visando o tratamento do Câncer de Mama
• Beneficiário: Giovanna Cassone Salata
• Modalidade de apoio: Bolsas no Brasil - Doutorado